Capri upgraded to buy at CFRA as it's trading below the $57 acquisition price being offered by Tapestry
CFRA upgraded Capri Holdings Ltd.'s stock (CPRI) to buy from hold on Wednesday, and said it's looking undervalued at its current price. The stock was last quoted at $49.28, below the $57 price offer from rival Tapestry Inc. (TPR), which is buying Capri in a deal expected to close in 2024. "We believe shares are now undervalued, trading well below the acquisition price and what we see as fair value," analyst Zachary Warring wrote in a note to clients. Capri, parent to Michael Kors, Versace and Jimmy Choo, is being acquired by Tapestry, parent to Coach, Kate Space and Stuart Weitzman for about $8.5 billion. Warring lowered his price target for Capri to $55 from $65 and cut his fiscal 2024 and fiscal 2025 EPS estimates by $1, to $5.50 and $6.00 respectively. The stock has fallen 14% in the year to date, while the S&P 500 has gained 19%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-22-23 1241ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters